Vileisis R A, Oh W
J Nutr. 1983 Feb;113(2):246-52. doi: 10.1093/jn/113.2.246.
The relationship between insulin-induced macrosomia and fetal fatty acid synthesis in nine pregnant rats was evaluated using the tritiated water technique. On days 19 and 21 of gestation, alternate fetuses were injected with equal volumes of either saline or insulin (5 units). Fetal hyperinsulinemia resulted in a significant increase in fetal weight and selected organ weights (liver, lung and carcass). Significant increases in fatty acid synthesis in fetal liver and carcass were observed on day 22 of gestation. In liver tissue, increased fatty acid synthesis occurred as evidenced by increased tritium incorporation into fatty acids in insulin-injected fetuses, 690 +/- 124 cpm/liver, compared to controls, 400 +/- 92 cpm/liver (P less than 0.001); higher fatty acid content, 16.0 +/- 1.3 mumol/liver in hyperinsulinemic fetuses, compared to 12.3 +/- 1.0 mumol/liver in controls (P less than 0.005); and a higher fatty acid specific activity, (expressed as tritium counts per minute per micromole fatty acid) 44.5 +/- 8.6 cpm/mumol fatty acid, compared to control levels of 33.0 +/- 7.5 (P less than 0.005). Analysis of carcass revealed higher tritium incorporation into fatty acids in insulin-injected fetuses, as compared to controls, 2136 +/- 172 versus 1139 +/- 122 cpm/carcass (P less than 0.001); higher fatty acid content, 68.1 +/- 7.3 versus 59.4 +/- 6.4 mumol/carcass (P less than 0.05); and fatty acid specific activity, 34.5 +/- 4.8 versus 21.9 +/- 4.4 cpm/mumol (P less than 0.001), respectively. There were no differences in the incorporation of tritium into fatty acids or fatty acid content in the lung, brain and placenta in the insulin-treated fetus as compared to control littermates. The data indicate that insulin is a lipogenic hormone for the fetus and that this model can be used as a means of studying effects of insulin on fat metabolism in fetal life.
采用氚水技术评估了9只妊娠大鼠中胰岛素诱导的巨大儿与胎儿脂肪酸合成之间的关系。在妊娠第19天和第21天,交替给胎儿注射等体积的生理盐水或胰岛素(5单位)。胎儿高胰岛素血症导致胎儿体重和选定器官重量(肝脏、肺和胴体)显著增加。在妊娠第22天观察到胎儿肝脏和胴体中脂肪酸合成显著增加。在肝脏组织中,与对照组相比,注射胰岛素的胎儿脂肪酸中氚掺入增加,证明脂肪酸合成增加,对照组为400±92 cpm/肝脏,注射胰岛素的胎儿为690±124 cpm/肝脏(P<0.001);高胰岛素血症胎儿的脂肪酸含量更高,为16.0±1.3 μmol/肝脏,而对照组为12.3±1.0 μmol/肝脏(P<0.005);脂肪酸比活性更高(以每分钟每微摩尔脂肪酸的氚计数表示),为44.5±8.6 cpm/μmol脂肪酸,而对照组水平为33.0±7.5(P<0.005)。对胴体的分析显示,与对照组相比,注射胰岛素的胎儿脂肪酸中氚掺入更高,分别为2136±172与1139±122 cpm/胴体(P<0.001);脂肪酸含量更高,为68.1±7.3与59.4±6.4 μmol/胴体(P<0.05);脂肪酸比活性分别为34.5±4.8与21.9±4.4 cpm/μmol(P<0.001)。与对照同窝仔相比,胰岛素处理的胎儿肺、脑和胎盘中氚掺入脂肪酸或脂肪酸含量没有差异。数据表明胰岛素是胎儿的生脂激素,该模型可作为研究胰岛素对胎儿期脂肪代谢影响的一种手段。